PACS Group, Inc. (PACS) Q3 2026 earnings review
PACS nursing homes raise their outlook, while stock costs jump
PACS Group, which operates nearly 400 nursing homes across the US, filled more beds at its existing facilities while restarting large acquisitions. Revenue from homes operated since the start of last year grew 6%, and operating cash profit excluding one-offs rose 34% to $176 million, well above what the company's own plan pointed to. Finance chief Carey Hendrickson raised the full-year outlook for a third time after closing deals for 43 additional facilities across Florida and Texas.
| Same-store skilled nursing revenue | +6.4% up from +5.8% last quarter |
|---|---|
| Total revenue | $1.50B +11.5% from a year ago |
| Profit per share, excluding one-offs | $0.63 +37% from a year ago |
| Full-year cash profit outlook | Raised $40M middle of the range: 37% growth |
⚖️ Verdict: 🟢 Bullish
The story got better because the company proved its earlier second-half plan was cautious and stepped up its expansion into new states. Older acquisitions continue to win higher federal quality ratings, which brings in better-paying patients and funds the next wave of deals. One caution: a $45 million stock-pay charge and rising reserves for patient liability claims held back reported profit, while federal billing investigations remain open.
The question now is whether PACS can turn around 54 newly acquired facilities in Texas and Florida as quickly as its earlier California homes while still fixing its internal accounting controls. If the operating model travels well, the new beds will lift margins over the next two years; if local state rates or staffing prove tougher, the lower-occupancy homes will weigh on profit. Fourth-quarter occupancy in the newest facility group and the year-end control audit will tell.
🐂 Bull Case
Same-Store Facilities and Star Ratings Lift Revenue
PACS Group operates skilled nursing facilities (SNFs), which care for patients recovering after a hospital stay. The group buys older homes and improves their clinical ratings to attract higher-paying patients. Chief executive Jason Murray noted that 250 facilities, or 78.9% of the portfolio, now hold four- or five-star federal quality ratings, up from 239 facilities in the second quarter.
- Same-store skilled nursing revenue: up 6.4% from a year ago, faster than the 5.8% growth in the second quarter
- Same-store bed occupancy: 91.3%, up 2 percentage points from a year ago
- Ramping facilities occupancy (owned for 18 to 36 months): 87.0%, up from 86.1% a year ago
- Managed care daily rate: $677.41 across all homes, up 5.4% from a year ago
Higher star ratings help PACS win contracts with private managed care insurers and fill beds with patients who need intensive daily nursing. Because these skilled patients bring an average daily rate of $837.66 compared to $340.12 for standard Medicaid residents, a 0.9 percentage point rise in the share of skilled patient days pushed revenue up and lowered direct patient care costs by 1.6 percentage points of revenue.
What to watch: same-store revenue growth in the quarterly filing once retroactive state bonus payments are stripped out. That clean figure will show whether underlying patient demand stayed above 6%.
Third Outlook Raise Proves Earlier Plan Was Cautious
Three months ago, management's full-year outlook pointed to second-half operating cash profit (adjusted EBITDA, which is profit before interest, taxes, depreciation, stock pay, and legal investigation fees) below the first-half pace. In the third quarter, PACS generated $175.7 million of adjusted EBITDA, up 33.6% from a year ago and 12.3% above the quarterly average implied by that earlier plan by our math.
Finance chief Carey Hendrickson raised the full-year adjusted EBITDA outlook by $40 million at the middle of the range, to $685–695 million. The new plan includes "approximately $5 million of EBITDA contribution from retroactive quality incentive payments in Ohio received in the month of October". Even without that one-off payment, by our math the outlook leaves $172.2 million for the fourth quarter, proving the summer slowdown implied by the old plan was simple caution.
What to watch: the initial 2027 adjusted EBITDA margin outlook when fourth-quarter results arrive. A target near 11.5% would show that newly acquired homes are not dragging down the group's profit rate.
Real Estate Ownership Expands Alongside Low Debt
PACS leases most of its nursing homes, which leaves it with $3.11 billion in balance-sheet lease liabilities, but the healthcare group is steadily buying more of its own buildings. During the third quarter, owned facilities rose to 66, up from 64 in August and 51 a year ago, while property and equipment on the balance sheet grew by $250.5 million over the first nine months to $1.45 billion.
Buying real estate protects PACS from annual rent escalations: rent expense fell by 0.5 percentage points of revenue from a year ago to 6.6%. Even after spending $403.8 million on acquisitions and real estate over nine months, net debt sits at 0.2 times yearly adjusted EBITDA, with $707.4 million in available cash and credit lines.
What to watch: how many of the 57 purchase options on leased and partnered facilities PACS exercises over the next year. Converting leases into owned buildings directly lifts operating margins by eliminating cash rent.
🐻 Bear Case
Acquisition Wave Restarts With Texas and Florida Deals
After pausing deals in 2025 to fix its accounting and digest earlier purchases, PACS is buying again. That expansion is both a growth driver and an operational risk: Murray said the move into Florida and expansion in Texas "significantly broaden our geographic reach", while the company targets "acquiring underperforming and moderately performing operations where its operating model can drive meaningful improvement".
The company spent $213.0 million on deals in the third quarter, adding 29 new facilities since June, and then closed on 32 nursing homes in Florida on October 1 and 11 facilities in Texas by November 1. Total operations jumped to 398 across 21 states from 344 in August. Taking over weaker facilities immediately diluted the New facility cohort (owned under 18 months), where bed occupancy dropped to 76.2% from 80.6% a year ago.
What to watch: occupancy and skilled patient mix in the New facility cohort in the fourth quarter, when all 32 Florida homes enter the table. A drop below 70% occupancy would show that turning around a brand-new state carries a heavier initial drag.
Stock Compensation and Liability Reserves Cut Into Profit
"Our third quarter results demonstrate the increasing earnings power of the PACS operating model, with Adjusted EBITDA growth significantly outpacing revenue growth," Hendrickson said. While adjusted EBITDA rose 33.6% from a year ago, reported net income grew less than half as fast at 16.2%, and operating margin barely moved, rising 0.2 percentage points to 6.7%.
- General and administrative overhead: 9.2% of revenue, up 1.6 percentage points from a year ago
- Stock-based compensation: $45.3 million, or 3.0% of revenue, up from $12.5 million a year ago and $25.8 million in the second quarter
- Legal and investigation costs: $9.5 million, down from $19.6 million a year ago but up from $8.2 million in the second quarter
- Accrued self-insurance liabilities for patient claims: $404.3 million, up 25.7% in nine months and up $37.6 million from June by our math
Adjusted EBITDA leaves out stock pay and investigation fees, but shareholders bear both costs. At the same time, the steady build in self-insurance reserves on the balance sheet shows that patient liability claims continue to climb as the bed count grows.
What to watch: the liability insurance expense line inside the quarterly filing's cost breakdown. If insurance costs rose by more than $25 million from a year ago as they did in the second quarter, claim inflation is eating into facility-level savings.
Risks this quarter didn't answer
Four standing legal, governance, and policy concerns received no update in the earnings release and await the full quarterly filing.
- Federal billing investigations: Department of Justice probes into Medicare billing and referral practices remain open; the quarterly filing's contingencies note will show if the government has asserted any financial claims.
- SEC investigation and shareholder lawsuits: PACS booked $9.5 million in legal and investigation fees this quarter; the filing will show whether any settlement reserve can now be estimated.
- Internal accounting controls: management previously promised to fix material weaknesses in financial reporting by the end of 2026; the fourth-quarter annual report is the test.
- California Medicaid concentration and lease obligations: almost half of PACS beds sit in California and undiscounted lease commitments approach $5 billion; the filing will show how much the Florida and Texas deals reduced the California share.
👓 Other Themes
Cohort Reshuffling Lowers Ramping Medicare Daily Rates
Average daily Medicare rates across all PACS nursing homes held steady at $945.96 compared to $950.49 a year ago, while Medicaid daily rates rose 1.4% to $340.12. Inside the Ramping cohort, however, the average Medicare daily rate fell 16.6% from a year ago to $826.68 because 47 older facilities in higher-rate states graduated into the Mature cohort and homes bought in 2025 took their place.
💲 Other KPIs
Cash generated from day-to-day operations reached $583.1 million for the first nine months, up 43.0% from a year ago. By our math, subtracting first-half cash flow leaves $211.2 million for the third quarter, up 3.1% from a year ago as working capital settled after large state incentive receipts earlier in the year.
Weighted-average diluted shares fell 0.5% from a year ago but rose by 1.9 million shares from the second quarter as employee stock awards vested. Management did not report any share repurchases under the $250 million buyback plan authorized in May.
🔮 Guidance
Raised. The middle of the full-year range moved up by $200 million to $6.0 billion, or 13.4% growth from last year. By our math, that leaves $1.65 billion of revenue for the fourth quarter, a 21.7% jump from a year ago as the newly closed nursing homes in Florida and Texas join the income statement. It is the second raise this year: $0M in Q1, +$100M in Q2, +$200M in Q3.
Raised. The middle of the range rose by $40 million to $690 million, representing about 37% growth over 2025. By our math, the plan leaves $177.2 million for the fourth quarter (up 24.7% from a year ago), or $172.2 million excluding a $5 million retroactive Ohio bonus received in October. This is the third raise in three quarters: +$50M, +$35M, +$40M.
❓ Key Questions
Did state bonus payments help Q3 same-store revenue?
Same-store skilled nursing revenue grew 6.4%, up from 5.8% in the second quarter, and management noted $5 million of Ohio retroactive payments arrived in October. Were any California or Ohio retroactive quality payments booked inside third-quarter revenue?
Why did stock-based compensation jump to $45.3 million?
Stock-based compensation more than tripled from a year ago and rose by $19.5 million from the second quarter, keeping operating margin at 6.7%. Was this caused by one-time executive grants or a permanent step-up in quarterly employee equity awards?
What are the starting margins of the 32 Florida homes?
PACS entered Florida on October 1 by acquiring 32 facilities and raised its full-year revenue outlook by $200 million. What occupancy rate and operating profit margin do those Florida homes carry today?
Why did patient liability reserves rise another $38 million?
Total accrued self-insurance liabilities on the balance sheet reached $404.3 million, up $108 million since December. How much of this increase comes from newly acquired facilities versus higher malpractice and liability claims at existing homes?
Are the accounting control weaknesses on track for year-end?
Management previously aimed to finish fixing material weaknesses in internal control over financial reporting by the end of 2026. With 54 facilities added since August, will the company still meet that year-end deadline?